Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events patient preferences considered first time fda decision approve first kind obesity
… (VNS), the treatment is currently underutilized. The time to initial implant occurs approximately 20 years after … utilization, and lower costs over a relatively short time period. VNS, a proven intervention, can be a … Related Services Health Economics Decision-Analytic Models Staff Members Dee Dee Mladsi …
… Solutions experts will be presented at DIA 2024. Effective patient engagement in patient experience data: practical insights from case studies … populations. Vass C . Presentation. #226: Effective Patient Engagement in Patient Experience Data: Practical …
… and supplementary data (e.g., natural history studies and patient registries) when evaluating the safety and efficacy of drugs for rare diseases and conditions FDA and EMA engagement of people with rare diseases and … conditions to elicit their lived experience to help the FDA and EMA develop guidance, policies, and programs …
… November 5 Special Event: Building Capacity to Collect Patient Preferences Information for Innovative Kidney Devices Developing Patient Preference Surveys: Methods to Evaluate Maximum …
… development and market access objectives. QoL Analyses Patient-centered outcomes and other quality of life (QoL) … to EQ-5D. Q-TWiST Analyses Q-TWiST (quality-adjusted time without symptoms or toxicity) is an approach that can … they place on different health outcomes. Even if patient-reported QoL data was not collected in your study, we …
… MS who are not responding to established first-line therapies. We combined these results with survey … this research represents an important step forward as the first study to use real-world effectiveness data in an …
… four years as a reviewer on the Health Care Technology and Decision Sciences Study Section at the Agency for Healthcare …
… to helping reduce risks to patients to ensuring that patient preference is considered in the development of new therapies—we are …
… will be presented at ADA's 84th Scientific Sessions. Preferences of people with type 2 diabetes for features of … C , Poon JL, Schapiro D, Pierce A, Mansfield C. Poster Patient reported burden of disease in diabetic peripheral neuropathic pain: learnings from in-depth patient interviews, sub-study of RELIEF-DPN 1. Gaudiani L, …
… 904. Outcomes Research—Non-Malignant Conditions: Poster II Time and Location: Sunday, December 11, 2022: 6:00 PM-8:00 PM … JC, DasMahapatra P, Bartelt-Hofer J. Poster Understanding patient preferences for chronic lymphocytic leukemia treatments. …